202TiP SOLTI-1805 TOT-HER3 trial: A window-of-opportunity trial of patritumab deruxtecan (HER3-DXd) in patients with treatment-naïve, early breast cancer
| Autor: | Oliveira, M., Cejalvo Andujar, J.M., Margeli Vila, M., Tolosa Ortega, P., Martinez Saez, O., Salvador Bofill, F.J., Cruz Jurado, J., Luna Barrera, A.M., Arumi de Dios, M.A., Vidal Losada, M.J., Guerra, J.A., Pernas Simon, S., Villacampa Javierre, G., Gonzalez-farre, B., Sanfeliu Torres, E., Santhanagopal, A., Falato, C., Ferrero Cafiero, J.M., Pascual, T., Prat, A. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S628-S628 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|